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Objectives We sought to determine whether the amount of noncalcified plaque (NCP) in nonobstructive coronary lesions as
detected by multidetector computed tomography (MDCT) was a predictor of future coronary events.
Background Patients presenting with non–ST-segment elevation myocardial infarction (NSTEMI) frequently have multiple cor-
onary plaques, which may be detected with MDCT.
Methods We included 312 consecutive patients presenting with NSTEMI, who underwent 64-slice MDCT coronary angiog-
raphy and coronary artery calcium scoring before invasive coronary angiography. All patients were treated ac-
cording to current guidelines based on an invasive treatment approach. Quantitative measurements of plaque
composition and volume were performed by MDCT in all nonobstructive coronary lesions. The endpoint was car-
diac death, acute coronary syndrome, or symptom-driven revascularization.
Results After a median follow-up of 16 months, 23 patients had suffered a cardiac event. Age, male sex, and diabetes
mellitus were all associated with an increasing amount of NCP. In a multivariate regression analysis for events,
the total amount of NCP in nonobstructive lesions was independently associated with an increased hazard ratio
(1.18/100-mm3 plaque volume increase, p  0.01). Contrary to this, neither Agatston score nor the amount of
calcium in nonobstructive lesions was associated with an increased risk.
Conclusions Multidetector computed tomography plaque imaging identified patients at increased risk of recurrent coronary
events after NSTEMI by measuring the total amount of NCP in nonobstructive lesions. The amount of calcified
plaque was not associated with an increased risk. (J Am Coll Cardiol 2011;58:502–9) © 2011 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.058Acute coronary syndrome (ACS) and sudden cardiac death
is frequently the first clinical manifestation of coronary
artery disease (CAD). The most common cause of ACS is
thrombus formation because of ruptured or eroded coronary
plaques (1–3). Coronary plaque disruption is typically associ-
ated with plaques containing a large necrotic core covered by a
thin fibrous cap (4). Despite optimal contemporary invasive
and medical treatment, the coronary event rate in patients with
ACS remains increased, compared with patients with stable
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accepted January 31, 2011.symptoms (5). Growing evidence suggest that this phenome-
non could be a consequence of multiple destabilized and
vulnerable plaques throughout the coronary tree (6–10).
See page 510
Noninvasive imaging of the coronary arteries with mul-
tidetector computed tomography (MDCT) has emerged as
an important modality in the diagnostic work-up of patients
suspected of CAD. Noncontrast-enhanced coronary artery
calcium scoring (CACS) has been shown to be an indepen-
dent marker of future coronary events in asymptomatic
individuals with coronary risk factors (11), and contrast-
enhanced MDCT coronary angiography (CAG) has proven
to be useful in ruling out significant obstructive atheroscle-
rotic disease in symptomatic patients with an intermediate
pre-test likelihood of CAD (12). In addition, visualization
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July 26, 2011:502–9 CT Plaque Imaging and Outcomeof coronary plaque composition has become possible with
this technique, allowing a fast noninvasive evaluation of the
overall plaque burden in the coronary tree with character-
ization of calcified and noncalcified plaque (NCP) compo-
nents (13–21).
In this prospective study, we tested the hypothesis that
global coronary plaque burden in nonobstructive lesions mea-
sured with MDCT predicts intermediate-term clinical out-
come in patients with non–ST-segment elevation myocardial
infarction (NSTEMI).
Methods
Patient selection and study design. In the period from
December 2006 to August 2008, all patients referred for
invasive CAG at our institution due to NSTEMI—defined
as acute chest pain, elevated troponin-T, and absence of
ST-segment elevation—were screened for participation in
the study (n  1,051). Exclusion criteria were elevated
erum creatinine (n  123), irregular heart rate (n  45),
hemodynamic/respiratory instability (n  12), allergy to
iodine contrast media (n  5), and refusal to participate (n
 40). Among eligible patients (n  826), it was not
possible to obtain scanning data in 504 for logistical reasons
(mainly due to scanner availability and coincidence with the
invasive procedure). Thus, the final study population con-
sisted of 322 patients. All included patients underwent
MDCT before invasive CAG, and both procedures were
performed within the same day. Treatment strategy was
performed on the basis of clinical and invasive findings
according to international guidelines blinded to MDCT
findings (22).
Medical history and cardiovascular risk profile of the
patients were acquired from hospital charts. The minimum
follow-up time was 6 months, and follow-up data were
gathered from an electronic database containing vital status
and discharge letters for all admissions in Denmark (Green
System, CSC Scandihealth, Aarhus, Denmark). The com-
posite endpoint was defined as cardiovascular death, myo-
cardial infarction (MI), unstable angina requiring hospital
stay, or symptom-driven revascularization. All patients gave
written informed consent, and the local ethics committee
approved the study protocol.
MDCT scan protocol. All patients were pre-treated with
oral beta-blockers, unless contraindicated. Image acquisi-
tion was performed with a 64-slice MDCT (Aquilion 64,
Toshiba, Tokyo, Japan). First, a non–contrast-enhanced,
prospectively electrocardiogram-triggered calcium score was
performed at 75% of the R–R interval.
Subsequently, a coronary computed tomography (CT)
angiography was performed with the following parameter
settings: 64  0.5 mm detector collimation, 120 to 135 kV
tube voltage, 380 to 450 mA tube current, 350 to 500 ms
gantry rotation time (heart rate-dependent). Intravenous con-
trast media (Visipaque 320, GE Healthcare, Chalfont St.
Giles, United Kingdom) was infused with a flow rate of 5 ml/s dwith a biphasic injection protocol.
First, a 70 to 100 ml contrast bolus
was injected (depending on ex-
pected scan time), followed by a 30
ml 70%/30% contrast/saline mix.
Finally, a 30-ml saline chaser was
injected. The automatic bolus trig-
gering technique was used for ini-
tiating image acquisition. An au-
tomatic raw data motion analysis
tool (PhaseXact, Toshiba) was
used to determine the optimal sys-
tolic and diastolic phases for re-
construction. Additional recon-
structions at end systole (30% to
40% of the R–R interval) and mid-
diastole (70% to 80% of the R–R
interval) were routinely recon-
structed. All phases were evaluated
to identify the optimal phase for
evaluation of each coronary artery.
Images were reconstructed with
0.5-mm slice thickness and incre-
ments of 0.3 mm. Finally, recon-
structions with a 2.0-mm slice
thickness and a 2.0-mm increment
were performed with 5% intervals
throughout the entire cardiac cycle for functional analysis.
Data analysis. All image data were transferred to an
external workstation (Vitrea 2, version 4.0, Vital Images,
Inc., Plymouth, Minnesota) for further analysis blinded to
clinical information and findings of the invasive CAG.
First, the noncontrast-enhanced images were evaluated with
the Agatston score. In patients with a history of revasculariza-
tion, coronary segments with stents were excluded.
Second, analysis of the contrast-enhanced images was
performed in all coronary arteries more than 1.5 mm in
diameter. The coronary arteries were evaluated for the
presence of any plaque in axial and multiplanar reconstruc-
tions. In patients with a history of bypass surgery, coronary
segments with a patent bypass graft distally were excluded
for further analysis. Patients with severe motion artifacts in
at least 1 major coronary artery were excluded for further
analysis. Patients with motion artifacts in side branches
were accepted, and only the coronary segment with motion
artifacts was excluded. In each coronary lesion—defined as
any plaque between 2 normal coronary segments—
measurements of plaque morphology were performed with a
dedicated software tool, SUREPlaque (Vitrea 2, version 4.0,
ital Images, and Toshiba Medical Systems), previously
alidated against intravascular ultrasound (IVUS) and eval-
ated in different clinical settings (14,23). The vessel cen-
erline was located with an automatic vessel-tracking algo-
ithm based on the opacification of the lumen. The plaque
nalysis performed by the software is based on an automatic
Abbreviations
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CACS  coronary artery
calcium scoring
CAD  coronary artery
disease
CAG  coronary
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CT Plaque Imaging and Outcome July 26, 2011:502–9technique on cross sections perpendicular to the vessel. In
cases of inaccuracies at side branches or in heavily calcified
plaques, manual corrections of the lumen border and vessel
wall were performed. Coronary plaque was defined as the
area between the outer contour of the vessel and the lumen
border. The total plaque volume was calculated as the sum of
all contiguous voxels between the outer vessel contour and the
lumen border. Within this plaque, plaque content exceeding a
threshold of 130 Hounsfield units (HU) was calculated as the
calcium volume and plaque content below 130 HU as NCP
volume. Finally, the mean attenuation of the NCP volume was
determined as the average HU corresponding to the entire
NCP lesion (Fig. 1). Intraobserver and interobserver variability
of plaque measurements was examined in a subgroup of 50
patients. Reproducibility calculations were performed on pre-
viously selected cardiac phases.
In all coronary segments, any visible plaque on MDCT—
regardless of the degree of stenosis—was evaluated. On the
basis of the results from the invasive angiography upon which
the clinical decision-making was based, plaques in coronary
segments without any obstructive lesion (diameter stenosis
50%) were defined as nonobstructive plaque. The sum of all
recorded nonobstructive volumes (mm3)/patient was calcu-
lated. In an additional analysis, mean plaque attenuation of
NCP in both nonobstructive and obstructive lesions was
recorded.
Left ventricular function was measured as previously
described (24).
Figure 1 Evaluation of Coronary Plaques With Computed Tomo
Example of a 64-year-old man presenting with non–ST-segment elevation myocardi
(LCX) (white arrow). This lesion has both calcified and noncalcified components (
proximal left anterior descending (LAD) artery (double arrow) (B). The plaque anal
verse sections (D). The blue color represents noncalcified plaque and yellow, calcStatistical analysis. Statistical analyses were performed
with SPSS (version 16.0, SPSS, Inc., Chicago, Illinois).
Receiver-operator characteristic (ROC) curves were com-
pared with MedCalc version 11.4. Numerical values are
presented as mean  SD, and categorical values are pre-
sented as frequencies and percentages unless otherwise
stated. For statistical comparisons, a 2-tailed t test for
ndependent samples was used for continuous values, and
he chi-square test was used for categorical variables. Nu-
erical values that were not normally distributed were
ompared with the Mann-Whitney U test and are presented
s median and interquartile range. Analysis of variance for
inear trend and chi-square test for trend were used to test
ifferences between ordered groups. Correlation between
alcified plaque and NCP volumes was assessed with Spear-
an correlation coefficient. Intra- and inter-observer vari-
bility was assessed with Bland-Altman analysis and the
ntraclass correlation coefficient.
The relationships among MDCT variables, clinical vari-
bles, and clinical outcome variables were assessed with Cox
roportional hazards regression. First, a univariable analysis
as performed for each of the following potential MDCT
redictors of clinical events: Agatston score, nonobstructive
CP volume, nonobstructive calcified plaque volume, total
onobstructive plaque volume, and number of coronary
egments with any nonobstructive plaque. Second, a multi-
ariate regression analysis for each MDCT predictor was
erformed to adjust for established clinical predictors (age,
y
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July 26, 2011:502–9 CT Plaque Imaging and Outcomepresence of multivessel disease, prior MI, and left ventric-
ular ejection fraction). The proportional hazard assumption
was checked through calculation of correlation between
Schoenfeld residuals and ranked survival times. The incre-
mental prognostic value of MDCT predictors to clinical
variables was assessed by calculating the area under curve for
ROC curves of nonobstructive plaque volumes  clinical
variables and clinical variables alone.
Results
Coronary CT angiography was performed in 322 patients.
Patients not included for logistical reasons tended to be
Clinical Characteristicsand In-Hospit l ManagementTable 1 Clinical Characteristicsand In-Hospital Management
n 312
Male 230 (74%)
Age (yrs) 61 12
Body mass index (kg/m2) 27 5
eGFR (ml/min) 84 23
Medical history
Diabetes 46 (15%)
Current smoker 118 (38%)
Hypercholesterolemia 171 (55%)
Hypertension 138 (44%)
Family history of CAD 132 (42%)
History of myocardial infarction or revascularization 74 (24%)
Heart rate (beats/min) 59 11
LVEF by MDCT (%) 58 13
Findings on invasive coronary angiography
1-vessel disease 112 (36%)
2-vessel disease 81 (26%)
3-vessel disease 49 (16%)
Left main disease 24 (8%)
Treatment decision
PCI 181 (58%)
CABG 53 (17%)
Medication at discharge
Aspirin 287 (96%)
Clopidogrel 246 (79%)
Beta-blocker 268 (86%)
Statin 231 (93%)
CABG  coronary artery bypass grafting; CAD  coronary artery disease; eGFR  estimated
lomerular filtration rate; LVEF  left ventricular ejection fraction; MDCT  multidetector com-
puted tomography; PCI  percutaneous coronary intervention.
Baseline Risk Factors Stratified by Tertiles of Nonobstructive NCPTable 2 Baseline Risk Factors Stratified by Tertiles of Nonobst
Risk Factors 0–118 mm3 (n  104) 118–3
Age (yrs) 56 12
Male 66 (64%)
Diabetes 10 (10%)
Current smoker 38 (37%)
Hypertension 36 (35%)
Hypercholesterolemia 58 (56%)
Family history of CAD 47 (45%)CAD  coronary artery disease; NCP  noncalcified plaque.older (66 vs. 61 years, p  0.001) and to have a poorer renal
function (estimated glomerular filtration rate 80 vs. 84
ml/min, p  0.001) and a higher prevalence of 3-vessel
disease (21% vs. 16%, p  0.04) but did not differ with
regard to risk factors or treatment strategy. In 10 of the
included patients (3%), at least 1 major coronary artery
segment was not evaluable due to motion artifacts, and these
patients were excluded from further analysis. These patients
did not differ in baseline characteristics from the final study
population, except for a significantly higher heart rate (69
15 beats/min vs. 59  11 beats/min) during MDCT.
Baseline characteristics of the remaining 312 patients are
delineated in Table 1. After exclusion of 42 coronary
egments with stents and 162 segments with chronic occlu-
ion or small vessel size, a total of 1,454 coronary artery
egments with plaques were identified and analyzed.
The median Agatston score was 349 (42 to 1,059) and
as correlated to the total NCP volume (r  0.69, p 
.001). Forty patients (13%) had an Agatston score of 0, and
4 of these had obstructive lesions (35% of 0-calcium
atients). In the entire study group, the mean number of
iseased segments/patient was 5.2  3.5.
The invasive CAGs identified 313 obstructive coronary
esions that subsequently were the target of revasculariza-
ion. The MDCT identified 1,141 nonobstructive lesions
hat were left untreated. The total nonobstructive NCP
olume stratified by tertiles is presented in Table 2 with
orresponding baseline risk factors. Advanced age, male sex,
nd diabetes were associated with higher nonobstructive
CP volumes.
Mean attenuation of NCP between obstructive and
onobstructive lesions was not significantly different (70 
4 vs. 71  26, p  0.16).
Intraobserver limits of agreement were 68 mm3 for
calcified and 125 mm3 for NCP volumes, whereas inter-
observer limits of agreement were 64 mm3 and 168
m3, respectively. The corresponding intraclass correlation
coefficients were 0.89, 0.91, 0.92, and 0.81, respectively.
After a median of 16 months of follow-up (range 6 to 30
months), 23 events had occurred, including 6 cardiovascular
deaths, 8 nonfatal MIs, 5 admissions with unstable angina
and repeated CAG, and 4 clinically driven revasculariza-
tions. Four patients were censored because of noncardiovas-
eve NCP Volume
bstructive NCP Volume in Tertiles
m3 (n  104) 348–1,741 mm3 (n  104) p Value
 12 66 10 0.001
75%) 86 (83%) 0.007
7%) 23 (22%) 0.01
45%) 33 (32%) 0.4
53%) 47 (45%) 0.08
65%) 45 (43%) 0.08
39%) 44 (42%) 0.13Volumructi
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CT Plaque Imaging and Outcome July 26, 2011:502–9cular deaths: 1 lung embolus, 1 cancer, and 2 severe
infections.
In the univariate Cox regression analysis, significant
MDCT plaque predictors of clinical events were nonob-
structive NCP volume, total nonobstructive plaque volume,
nonobstructive calcified plaque volume, and number of
segments with any nonobstructive plaque. In 5 separate
multivariate models for each MDCT plaque predictor, only
the nonobstructive NCP volume and total nonobstructive
plaque volume were significant predictors of cardiac events
after adjusting for the following clinical variables: age,
presence of multivessel disease, history of MI, and left
ventricular ejection fraction (Table 3). Adjusted survival
curves based on stratification of NCP-volumes in tertiles are
shown in Figure 2. In an additional analysis for hard events
only (death or MI), the univariate hazard ratio for nonob-
structive NCP was 1.14 (p 0.04). There was no difference
n mean plaque attenuation of nonobstructive NCP between
atients with and those without events (71  25 vs. 72 
3, p  0.24).
Figure 2 Adjusted Survival Curves
Survival curves for the study population stratified in tertiles of the nonobstructive
prior myocardial infarction, and left ventricular ejection fraction (p  0.056 for firs
Univariate and Adjusted MDCT Plaque Predictors of Coronary EvenTable 3 Univariate and Adjusted MDCT Plaque Predictors of Co
Univaria
Agatston score 1.02
Nonobstructive NCP volume (per 100 mm3 increase) 1.17
Total nonobstructive plaque volume (per 100 mm3 increase) 1.06
Nonobstructive calcified plaque volume (per 100 mm3 increase) 1.07
Number of segments with any nonobstructive plaque 1.13
Adjusted for age, presence of multivessel disease, prior myocardial infarction, and left ventricular
CI  confidence interval; HR  hazard ratio; MDCT  multidetector computed tomography; NCThe area under the curve of ROC curves for nonobstruc-
ive NCP clinical variables was 0.70 (p 0.001), 0.68 for
total nonobstructive plaque volume clinical variables, 0.66
p  0.02) for nonobstructive calcified plaque  clinical
variables, and 0.61 (p  0.04) for clinical variables alone
(Fig. 3). Only area under the curve for NCP  clinical
variables was significantly higher than clinical variables
alone (p  0.04).
Discussion
To our knowledge, this study is the first to demonstrate that
evaluation of nonobstructive coronary lesions with MDCT
identifies patients at an increased risk after an acute coro-
nary event. Indeed, the nonobstructive NCP volume was a
better predictor of future cardiac events than clinical vari-
ables and LVEF. Furthermore, we demonstrated that NCP
was a stronger predictor than both the calcified and total
plaque volume.
cified plaque volume adjusted for age, presence of multivessel disease,
econd tertile, and p  0.034 for first vs. third tertile).
ry Events
(95% CI) p Value Adjusted HR (95% CI) p Value
–1.09) 0.34 1.01 (0.96–1.06) 0.59
–1.30) 0.002 1.18 (1.06–1.31) 0.002
–1.10) 0.005 1.06 (1.01–1.11) 0.01
–1.14) 0.02 1.07 (0.99–1.16) 0.06
–1.26) 0.04 1.12 (0.94–1.26) 0.24
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July 26, 2011:502–9 CT Plaque Imaging and OutcomeCurrent guidelines for the management of patients with
NSTEMI include pharmacological stabilization, CAG, and
revascularization of obstructed vessels (22). However, pa-
tients presenting with ACS have an increased risk of
recurrent coronary events even after optimal contemporary
invasive and medical treatment, and the presence of multi-
ple vulnerable plaques might play an important role.
The importance of identifying nonculprit vulnerable
plaques has previously been demonstrated in patients with
MI. Both Goldstein et al. (9) and Rioufol et al. (25) showed
that patients with multiple complex lesions had worse
clinical outcomes than patients with a single lesion. Mau-
riello et al. (8) found that patients dying from MI had an
average of 6.8  0.5 vulnerable segments compared with
0.8  0.3 vulnerable segments in patients with stable
ngina. However, the clinical implications of detecting
dditional vulnerable plaques remain controversial, and
maging criteria to identify patients at risk are still being
valuated.
Plaques prone to rupture or erosion have been shown to
ontain a large necrotic core covered by a thin fibrous cap,
hereas only a minority of the predominantly calcified
laques are involved in acute thrombus formation (1–4).
Comparisons of MDCT with IVUS for the characteriza-
Figure 3 Receiver-Operator Characteristic Curves
Receiver-operator characteristic curves created as a combination of multidetector
ability to predict coronary events. Area under the curve for noncalcified plaque (NC
cified plaque  clinical variables, 0.66 (p  0.02); and clinical variables alone, 0.
higher than clinical variables alone (p  0.04).ion of plaque morphology have shown an excellent agree-ment for the identification of noncalcified and calcified
plaques (15,19,26–28). However, the spatial resolution with
current CT scanners is still inadequate to differentiate
between subtypes of NCPs. Preliminary studies comparing
fibrous, fibro-fatty, and lipid-rich plaque components on
the basis of CT attenuation values have shown substantial
overlap (15,19,26,28–30). Nevertheless, distinct differences
between culprit lesions in ACS and lesions in stable angina
have been reported, with MDCT showing a significantly
higher frequency of noncalcified and mixed plaque types,
positive remodeling, and lower signal intensity in plaques
associated with ACS (13,14,18,20). Although current
MDCT scanners might not be able to detect the individual
vulnerable plaque, we hypothesized that the total NCP
volume could serve as a marker of the overall vulnerable
plaque burden.
Coronary artery calcium scoring with MDCT has been
introduced as a noninvasive method to detect coronary
artery plaques in asymptomatic persons with risk factors
(11). However, acute coronary events are usually triggered
by plaque disruption in NCPs (1,2,4), and the prognostic
value of CACS in patients with known CAD has not been
established. The correlation between calcified plaque and
NCP is assumed to be linear, thus making CACS a
ted tomography plaque measurements and clinical variables demonstrating the
linical variables, 0.70 (p  0.001); total plaque volume, 0.68 (p  0.001); cal-
 0.04). Only area under the curve for NCP  clinical variables was significantlycompu
P)  c
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CT Plaque Imaging and Outcome July 26, 2011:502–9tion might be reasonable in asymptomatic individuals with
a low prevalence of coronary atherosclerosis but has not
been assessed in patients with known CAD.
In this study, 2 important findings with regard to CACS
in patients with NSTEMI should be noted. Forty patients
(13%) had an Agatston score of 0, of which 14 (35%) had
obstructive lesions. A calcium score of 0 thus seems to be a
relatively common finding in patients with NSTEMI. In
the remaining 26 patients (65% of 0-calcium score patients),
no obstructive lesions were found representing a range of
conditions that might mimic NSTEMI (i.e., pericarditis or
myocarditis, coronary spasms, tachyarrhythmias, Takotsubo
syndrome). The second key finding with regard to CACS
was that the relationship between Agatston score and total
NCP volume was only moderate. These findings suggest
that, in patients with known CAD, further risk stratification
relies on measurements of the NCP burden and not on
detection of calcifications in the coronary arteries.
The prognostic value of detecting the burden of CAD by
MDCT in predicting all-cause mortality in patients with
stable symptoms was recently demonstrated by Ostrom et al.
(31). In another MDCT study, Motoyama et al. (17) found
a strong association between plaques with low attenuation
and positive remodeling and the development of ACS in
1,059 patients with stable symptoms. Of 45 patients classi-
fied to have vulnerable plaques, 10 (22%) developed ACS
within a mean follow-up of 27 months. Their study has
demonstrated that detection of vulnerable plaque with
MDCT is feasible. However, in our study we found no
difference in plaque attenuation of NCP between nonob-
structive and obstructive lesions. This finding has previously
been shown in a study using both MDCT and IVUS in
patients with ACS (16). Similarly, we found no difference in
plaque attenuation between patients with and those without
events. These observations could be explained by the fact
that patients with ACS are more likely to have diffuse
involvement of several coronary arteries, compared with
patients with stable CAD, and that, therefore, a small
difference in plaque attenuation remains undetectable.
In conclusion, MDCT plaque imaging of patients with
ACS could potentially lead to identification of patients who
might benefit from new pharmacological or invasive pre-
ventive strategies.
Study limitations. First, follow-up time was limited, re-
sulting in a relatively small number of clinical events, which
weakened the statistical strength of the multivariate analysis.
However, this study should be considered a proof-of-
concept study, and the a priori hypothesized predictor was
highly significant, allowing a less conservative strategy for
inclusion of established clinical covariates in the multivariate
model (32). Although nonobstructive NCP was a significant
predictor in both univariate and multivariate analysis, a
number of other possible clinical variables were not ex-
plored. Follow-up data were obtained from electronic dis-
charge letters, and evaluation of new culprit lesions in the
event group did not permit a lesion-specific comparisonwith our MDCT data. Larger studies with longer follow-up
and comparison with event-driven CAGs are required to
further establish MDCT criteria of plaque vulnerability.
Second, a substantial number of patients were not included
for logistical reasons—mainly due to scanner availability and
coincidence with invasive CAG. Patients not included in
the study for logistical reasons were similar to included
patients with regard to all clinical and angiographic charac-
teristics except for age, renal function, and a slightly higher
prevalence of 3-vessel disease. Although the differences
ere minor, this could potentially limit the generalization of
ur results. Third, we acknowledge that the MDCT tech-
ique needs further technical improvement. Reproducibility
f plaque volume measurements remains suboptimal, and
ith the observed limits of agreement, the risk of being
isclassified to the wrong group of tertiles should be
onsidered. In addition, reliable criteria for defining various
laque components on the basis of attenuation need to be
stablished. Multi-energy is a promising new technique that
ould improve this discrimination of plaque components.
inally, radiation and total contrast load are issues of
oncern when adding a coronary CT angiography to the
iagnostic work-up in patients with ACS. However, new
canner types with radiation doses as low as 1 mSV with
rospective electrocardiogram-triggering have recently been
ntroduced, allowing a more liberal use of the technique
33). The contrast required to perform a coronary CT
ngiography during the index admission could increase the
isk of developing contrast-induced nephropathy. Neverthe-
ess, during follow-up, none of the patients included in the
tudy were admitted for renal insufficiency. Future studies
hould evaluate the risk/benefit ratio of sequential cardiac
T and invasive catheterization. In this type of patient,
verall contrast use could remain unchanged or even decline,
ecause presence, extent, and characteristics of coronary
athology identified by cardiac CT could reduce the amount
f subsequent contrast injection needed during invasive
atheterization.
onclusions
oronary CT angiography identified patients at increased
isk of recurrent coronary events after NSTEMI by mea-
uring the total amount of NCP in nonobstructive lesions
nd was a better predictor of events than clinical variables.
he amount of calcified plaque was not associated with an
ncreased risk. This method could be useful for identifying
atients at risk after an episode of ACS and guide new
reventive strategies.
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